Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier for advanced OPTIONS screeners and volatility tools. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Orexigen Therapeutic (OREX)

Orexigen Therapeutic (OREX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 4,212
  • Shares Outstanding, K 18,890
  • Annual Sales, $ 33,710 K
  • Annual Income, $ -24,520 K
  • EBIT $ N/A
  • EBITDA $ N/A
  • 60-Month Beta 2.46
  • Price/Sales 0.06
  • Price/Cash Flow N/A
  • Price/Book N/A
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm -10.51
  • Most Recent Earnings $-1.35 on 11/13/17
  • Next Earnings Date 05/08/18
  • Annual Dividend & Yield 0.00 (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Sell
Based on 1 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/18
See More
  • Average Estimate N/A
  • Number of Estimates 0
  • High Estimate N/A
  • Low Estimate N/A
  • Prior Year -4.67
  • Growth Rate Est. (year over year) +21,491.86%

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.17 +31.18%
on 03/27/18
1.42 -84.30%
on 03/09/18
-0.99 (-81.57%)
since 03/02/18
3-Month
0.17 +31.18%
on 03/27/18
1.60 -86.06%
on 02/22/18
-1.02 (-82.02%)
since 01/03/18
52-Week
0.17 +31.18%
on 03/27/18
3.81 -94.15%
on 04/27/17
-2.61 (-92.12%)
since 04/03/17

Business Summary

OREXIGEN THERAPEUTICS, INC. is a biopharmaceutical company focused on the development of pharmaceutical product candidates for the treatment of central nervous system disorders, including obesity. The Company's lead combination product candidates targeted for obesity are Contrave, which is in Phase III...

See More

Key Turning Points

3rd Resistance Point N/A
2nd Resistance Point 0.35
1st Resistance Point 0.29
Last Price 0.22
1st Support Level 0.19
2nd Support Level 0.15
3rd Support Level N/A

See More

52-Week High 3.81
Fibonacci 61.8% 2.42
Fibonacci 50% 1.99
Fibonacci 38.2% 1.56
Last Price 0.22
52-Week Low 0.17

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar